COVID-19. COVID-19 ,virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with Covid 19 based on CT scan or PCR. Patients with fasting blood sugar above 100 at the time of referral Patients with previous diagnosis of diabetes and under treatment Study and accept consent to participate in the study Patients over 18 years of age
Exclusion criteria
Exclusion criteria: Acute renal failure, chronic renal failure with stage 4,5 Acute and chronic liver failure History of immunodeficiency diseases, using immunodeficiency drugs Pregnancy and breastfeeding Patients who are admitted to the intensive care unit upon arrival Patients with contraindications to cytagliptin (pancreatitis and its history, diabetic gastroparesis, history of severe drug allergy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| O2 saturation without mask. Timepoint: Daily. Method of measurement: Thermometer.;Fasting blood suger. Timepoint: Daily, From admission to discharge time. Method of measurement: Glucometer.;Covid-19 infection. Timepoint: At the beginning of the hospital admission. Method of measurement: Covid RT-PCR test.;Disease severity. Timepoint: At the beginning and end of intervention. Method of measurement: Based on protocol and clinical symptoms.;Cbc diff. Timepoint: every other day in between from the beginning of hospitalization until discharge. Method of measurement: labratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization duration. Timepoint: discharge time. Method of measurement: clinical record.;Death. Timepoint: at the end of study. Method of measurement: medical record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Artesh University of Medical Sciences